Hedgehog信号通路调控大鼠睑板腺上皮细胞增殖与分化
本研究从大鼠睑板腺导管分离上皮细胞(RMGECs)并传至第二代,在MGECM中培养后换用分化培养基或含10 µg/mL阿奇霉素的分化培养基,用Smo激动剂SAG和拮抗剂环巴胺干预,通过qRT-PCR、增殖分析、免疫荧光和尼罗红染色检测。结果显示Hedgehog受体Smo及下游Gli在体内外均表达,且随分化增加而减少;环巴胺减少细胞数和Ki67表达并促进SREBP1表达和脂质生成,SAG抑制SREBP1表达和脂质积累但对细胞数和Ki67无显著影响。结论提示Hedgehog通路在RMGECs增殖与分化中起重要作用,可能为睑板腺功能障碍(MGD)提供潜在治疗途径。
要点
- Smo和Gli1在RMGECs体内外均表达,且随体外分化增加而减少。
- 环巴胺减少MGECM中细胞数和Ki67表达,促进DM+AZM中SREBP1表达和脂质生成。
- SAG抑制DM+AZM中SREBP1表达和脂质积累,但对MGECM中细胞数和Ki67无显著影响。
核心结论
- Hedgehog信号通路在大鼠睑板腺上皮细胞增殖与分化中起重要作用,可能成为治疗睑板腺功能障碍的潜在靶点。
研究设计与样本
- 从大鼠睑板腺导管分离上皮细胞(RMGECs),在Matrigel包被孔中用MGECM培养至第二代,于50%–60%融合时换用分化培养基(DM)或含10 µg/mL阿奇霉素的DM(DM+AZM)。
- 使用Smo激动剂SAG和拮抗剂环巴胺干预,通过定量RT-PCR、细胞增殖分析、免疫荧光染色和尼罗红染色分析效应。
主要发现
- Hedgehog受体Smo及其下游分子Gli在体内和体外均表达,Smo和Gli1随体外分化增加而减少。
- 环巴胺减少MGECM中细胞数和Ki67表达,并促进DM+AZM中SREBP1表达和脂质生成。
- SAG抑制DM+AZM中SREBP1表达和脂质积累,但对MGECM中细胞数和Ki67表达无显著提升作用。
临床怎么用
- Hedgehog通路可能作为调控睑板腺上皮细胞增殖与分化、干预睑板腺功能障碍的潜在治疗方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Meibomian glands play a vital role in maintaining ocular surface stability. This study aimed to investigate whether Hedgehog signaling is involved in the regulation of meibomian gland epithelial cells. METHODS: Rat meibomian glands epithelial cells (RMGECs) were isolated from ducts and ductules, and then were cultivated to passage two on Matrigel coated wells in meibomian gland epithelial cells medium (MGECM). Cells were switched from MGECM to differentiation medium (DM) or DM added 10 µg/mL azithromycin (DM + AZM) when reached 50% to 60% confluence. The effects of the Smoothened (Smo) agonist (Smo agonist [SAG]) and antagonist (by cyclopamine) on RMGECs were analyzed using quantitative RT-PCR, cell proliferation analysis, immunofluorescence staining, and Nile red staining. RESULTS: The Hedgehog receptor, Smo, and its downstream molecules, Glis, were expressed both in vivo and in vitro. Smo and Gli1 both decreased with the increase of differentiation in vitro. Smo antagonist, cyclopamine, reduced cell numbers, and the expression of Ki67 in MGECM, and promoted the expression of SREBP1 and lipid production in DM + AZM. Smo agonist, SAG, inhibited the expression of SREBP1 and lipid accumulation in DM + AZM but showed no significant effects on raising cell numbers and the expression of Ki67 in MGECM. CONCLUSIONS: The Hedgehog signaling pathway appears to play important roles in RMGECs proliferation and differentiation. This may provide a potential therapeutic way to treat meibomian gland dysfunction (MGD).
引用
- Qu JY, Xiao YT, Zhang YY, et al. Hedgehog Signaling Pathway Regulates the Proliferation and Differentiation of Rat Meibomian Gland Epithelial Cells. Invest Ophthalmol Vis Sci. 2021. PMID: 33616621. doi:10.1167/iovs.62.2.33
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。